S L Soignet

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi request reprint Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemia
    S L Soignet
    Developmental Chemotherapy, Department of Medicine, Memorial Sloan Kettering Cancer Center, Cornell University Medical College, 1275 York Avenue, New York, NY 10021, USA
    Cancer Chemother Pharmacol 44:417-21. 1999
  2. ncbi request reprint Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia
    S L Soignet
    Memorial Sloan Kettering Cancer Center and Department of Medicine, New York, New York 10021 6007, USA
    Oncologist 6:11-6. 2001
  3. ncbi request reprint United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
    S L Soignet
    Leukemia and Developmental Chemotherapy Services, Department of Medicine, Memorial Sloan Kettering Cancer Center and Joan and Sanford Weill Medical College of Cornell University, New York, NY 10021, USA
    J Clin Oncol 19:3852-60. 2001

Detail Information

Publications3

  1. ncbi request reprint Clinical study of an organic arsenical, melarsoprol, in patients with advanced leukemia
    S L Soignet
    Developmental Chemotherapy, Department of Medicine, Memorial Sloan Kettering Cancer Center, Cornell University Medical College, 1275 York Avenue, New York, NY 10021, USA
    Cancer Chemother Pharmacol 44:417-21. 1999
    ....
  2. ncbi request reprint Clinical experience of arsenic trioxide in relapsed acute promyelocytic leukemia
    S L Soignet
    Memorial Sloan Kettering Cancer Center and Department of Medicine, New York, New York 10021 6007, USA
    Oncologist 6:11-6. 2001
    ..Additional trials are under way to evaluate the use of this agent alone or as part of a chemotherapy regimen for consolidation and maintenance of patients with APL...
  3. ncbi request reprint United States multicenter study of arsenic trioxide in relapsed acute promyelocytic leukemia
    S L Soignet
    Leukemia and Developmental Chemotherapy Services, Department of Medicine, Memorial Sloan Kettering Cancer Center and Joan and Sanford Weill Medical College of Cornell University, New York, NY 10021, USA
    J Clin Oncol 19:3852-60. 2001
    ..To determine the safety and efficacy of arsenic trioxide (ATO) in patients with relapsed acute promyelocytic leukemia (APL)...